Alcon Inc. (ALC): Price and Financial Metrics

Alcon Inc. (ALC): $70.12

0.05 (+0.07%)

POWR Rating

Component Grades














  • ALC scores best on the Growth dimension, with a Growth rank ahead of 92.58% of US stocks.
  • The strongest trend for ALC is in Value, which has been heading up over the past 179 days.
  • ALC's current lowest rank is in the Momentum metric (where it is better than 10.51% of US stocks).

ALC Stock Summary

  • With a market capitalization of $33,366,762,000, ALCON INC has a greater market value than 93.12% of US stocks.
  • ALC's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 116.41 -- higher than 81.47% of US-listed equities with positive expected earnings growth.
  • ALC's current price/earnings ratio is 58.44, which is higher than 90.53% of US stocks with positive earnings.
  • Stocks that are quantitatively similar to ALC, based on their financial statements, market capitalization, and price volatility, are FTV, CSGP, XYL, CARR, and PKI.
  • ALC's SEC filings can be seen here. And to visit ALCON INC's official web site, go to

ALC Valuation Summary

  • In comparison to the median Healthcare stock, ALC's price/sales ratio is 18.75% lower, now standing at 3.9.
  • Over the past 44 months, ALC's price/earnings ratio has gone up 183.8.

Below are key valuation metrics over time for ALC.

Stock Date P/S P/B P/E EV/EBIT
ALC 2022-11-25 3.9 1.7 58.8 48.5
ALC 2022-11-23 3.8 1.7 58.5 48.3
ALC 2022-11-22 3.8 1.7 57.6 47.6
ALC 2022-11-21 3.7 1.7 56.8 47.0
ALC 2022-11-18 3.7 1.6 56.6 46.8
ALC 2022-11-17 3.7 1.6 55.8 46.3

ALC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ALC has a Quality Grade of C, ranking ahead of 38.86% of graded US stocks.
  • ALC's asset turnover comes in at 0.284 -- ranking 134th of 186 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows ALC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.284 0.508 0.035
2021-03-31 0.252 0.448 -0.033
2020-12-31 0.249 0.430 -0.052
2020-09-30 0.248 0.438 -0.075
2020-06-30 0.249 0.451 -0.065
2020-03-31 0.273 0.489 -0.023

ALC Stock Price Chart Interactive Chart >

Price chart for ALC

ALC Price/Volume Stats

Current price $70.12 52-week high $88.78
Prev. close $70.07 52-week low $55.21
Day low $69.15 Volume 688,500
Day high $70.44 Avg. volume 892,796
50-day MA $61.33 Dividend yield N/A
200-day MA $69.81 Market Cap 34.36B

Alcon Inc. (ALC) Company Bio

Alcon is an American Swiss medical company specializing in eye care products with headquarters in GenevaSwitzerland, and incorporated in Fribourg, Switzerland. Alcon began as a US company and its US subsidiary’s headquarters remain in Fort Worth, Texas, where the Alcon division of the company was founded. (Source:Wikipedia)

ALC Latest News Stream

Event/Time News Detail
Loading, please wait...

ALC Latest Social Stream

Loading social stream, please wait...

View Full ALC Social Stream

Latest ALC News From Around the Web

Below are the latest news stories about ALCON INC that investors may wish to consider to help them evaluate ALC as an investment opportunity.

Alcon's (ALC) Latest Buyout to Enhance Its Product Portfolio

Alcon's (ALC) ophthalmic pharmaceutical product suite is expected to be significantly boosted by adding new products following the recent acquisition.

Yahoo | November 24, 2022

Alcon (ALC) Q3 Earnings Surpass Estimates, Sales Guidance Cut

Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the strength in its comprehensive portfolio of PCIOLs, including PanOptix and Vivity.

Yahoo | November 23, 2022

Durham loses public company HQ with Alcon-Aerie deal complete

Former executives at Aerie Pharmaceuticals are in line for major payouts totaling millions of dollars now that the merger with Alcon is complete.

Yahoo | November 23, 2022

Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business

GENEVA, November 22, 2022--Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business

Yahoo | November 22, 2022

Alcon: Eyeing A Growth Story That Could Benefit From A Weaker Dollar (NYSE:ALC)

It''s rare to find a high-growth foreign company that isn''t stuck in a big downtrend.

Seeking Alpha | November 18, 2022

Read More 'ALC' Stories Here

ALC Price Returns

1-mo 21.36%
3-mo N/A
6-mo -7.51%
1-year -11.51%
3-year 26.87%
5-year N/A
YTD -19.51%
2021 32.04%
2020 16.63%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.712 seconds.